Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
GSK SWOT Analysis – PortersFiveForce.com
GSK PLC's Dividend Analysis
GSK plc (GSK): VRIO Analysis
GSk financial statement analysis | PPTX
GSK GSK Plc Stock Analysis | Trading Signal & Price Prediction ...
Gsk financial analysis | PPTX
Shareholder Value Analysis of GSK
GSK Pharma Case Study: Business Model and SWOT Analysis - Pocketful
GSK | 01 October 2024 | AI Stock Analysis & News – Predicto AI ⚡
SWOT Analysis of GSK | SWOT & PESTLE Analysis
GSK Performance Report: Financial & Strategic Analysis
GSK - Financial Statement analysis - Financial Accounting Term Project ...
Draft 1 - Phong's GSK Analysis.pdf - GlaxoSmithKline's Case Analysis ...
Is GlaxoSmithKline a Buy Now!? | GSK Stock Analysis - YouTube
GSK Analysis of Company.docx - 1 GSK Analysis of Company Student Name ...
GSK Pharma Shares Complete Fundamental Analysis - Eloquens
GSK plc (LON: GSK) Stock Price Quote & Overview - Stock Analysis
GSK Pharma Stock Analysis by Ketan Mittal (SEBI RA)
Principal Component Analysis plots. Chemical diversity of the GSK ...
Financial Performance A Case Analysis of GlaxoSmithKline plc GSK .docx ...
GSK (GSK) Stock Price & Analysis Today
GSK plc (LON: GSK) Stock Price & Overview - Stock Analysis
Guggenheim Boosts GSK Stock: Comprehensive Analysis - Birmingham Journal
1. Measurement System Analysis - Dr. GSK - YouTube
MEASUREMENT SYSTEM ANALYSIS Dr GSK 18 MAY - YouTube
GSK DESIGN Web Design Analysis | DesignRush
GSK - Echo Research Case Study - Media Analysis - Stakeholder ...
Gsk organizational presentaion | PPTX
Gsk GSK Seeks To Strengthen China Connections TipRanks.com
GSK at a Glance | PDF
GSK PLC-SPON ADR (NYSE:GSK) Presents a High-Probability Technical ...
GSK (GlaxoSmithKline) - Managing Change
Is GSK Stock a Buy Now!? | GSK Stock Analysis! | - YouTube
Glaxosmithkline Share Price in 2008: Chart, Monthly Trends, & Analysis
GSK Stock Price and Chart — NYSE:GSK — TradingView
GlaxoSmithKline ($GSK) - Quick Stock Analysis - YouTube
GSK SWOT Analysis: Vaccines and ViiV Leadership with Haleon Legacy ...
GlaxoSmithKline Pharma Q2 Results 2026 🔥 | GSK Pharma Results Today ...
GSK (GlaxoSmithKline) | Statista
Financial ratio analysis GSK.docx - GlaxoSmithKline Financial Ratio ...
GlaxoSmithKline (GSK) Stock Price, Quote, News & Analysis - TipRanks.com
GSK plc (GSK): Analyzing the Recent -14% Drop and What Lies Ahead
GSK turns to AI specialist Tempus for R&D productivity boost | pharmaphorum
GSK Stock: Why I'm Picking Up This Undervalued Gem (NYSE:GSK) | Seeking ...
GlaxoSmithKline (GSK) - Stock Analysis - YouTube
GlaxoSmithKline Company Analysis – Inside Simple Finance
GlaxoSmithKline (GSK) Business Environment Analysis Report
GSK to buy RAPT Therapeutics in deal valued at $2.2B (GSK:NYSE ...
GSK Completes $2.2 Billion Acquisition of RAPT Therapeutics for Food ...
GSK declares positive results from phase III trial for Blenrep in ...
GSK Shares (LON: GSK) | AskTraders.com
Top Competitors of Sanofi: Comprehesive Analysis of Pharma
GSK gets wide FDA approval for myelofibrosis drug | pharmaphorum
How to Invest in GlaxoSmithKline and Buy/Sell GSK Share CFDs in 2024 ...
GSK reaches $2.2bn deal to buy food allergy biotech RAPT | pharmaphorum
GSK plc (GSK) Stock Price - Chart, News, Analysis, Signals ...
GSK (NYSE:GSK) Stock Unloaded Rep. Lisa C. McClain
GSK PLC (GSK.L) Stock Analysis: Key Insights Into Growth Potential And ...
GSK Presents Two Cancer Datasets at ESMO | AskTraders.com
GSK planning 1,200 job cuts in Belgium, says paper | pharmaphorum
Walmsley to leave GSK in surprise exit | pharmaphorum
GSK (LSE:GSK) Secures Exclusive Rights To A First In Class KRAS EGFR ...
GSK rises after strong Q2 results and growth plan update | Quiver ...
GSK wins FDA green light for chronic hep B treatment Hibsago | pharmaphorum
GSK rectal cancer drug clears tumours in 76% of patients without ...
GSK Accelerates Cancer Drug Development Amid Strategic Acquisiti
GSK Plans Up to 1,217 Job Cuts in Belgium Amid Restructuring
GSK stock holds steady amid consolidation near a key level
GSK cancer drug clears rectal tumours in 76% of patients in trial, data ...
MerzAesthetics – Business Snapshot & Rival Analysis – 2026
HUTCHMED closes $110M licensing deal with GSK for cancer therapy By ...
GSK in Talks to Acquire Nuvalent for Over $9 Billion – FT Report
Over $800 million investment from GSK to expand operations in ...
GSK gets positive results in drug trials for rectal and ovarian cancer ...
GSK Reports 76% Complete Response Rate for Jemperli in Phase II Rectal ...
GSK plc 2026 Q1 - Results - Earnings Call Presentation (NYSE:GSK) 2026 ...
Why is GSK stock up 1.6% today?
GSK commits more than $800m to Pennsylvania hub and 300 new jobs
Hansoh and GSK drug extends survival in bone cancer study By Investing.com
Summary of GSK's analysis. (a) Composition of GSK's demographic ...
Understanding the Setup: (GSK) and Scalable Risk - Stock Traders Daily
3._Financial_Analysis_-_Pfizer_Vs_GSK.PDF
Will GSK's Seasonal Strength and Oncology Focus Drive Gains? - seasonax
H/R induces the expression of GSK-3 isoforms in mitochondria ...
(A) Bar graph represents quantification of GSK-3 kinase activities by ...
Gaining Insight into GSK’s Optimized Record to Report Process - SAPinsider
GlaxoSmithKline (GSK) Share Price Prediction (2025-2030): Expert ...
Exploring Novel GSK-3β Inhibitors for Anti-Neuroinflammatory and ...
Amid tariff turmoil, Novartis commits to spending $23B on US ...
GLAXOSMITHKLINE SHARE TARGET ♒️ GLAXOSMITHKLINE SHARE NEWS ...
GLAXOSMITHKLINE PHARMACEUTICALS SHARE LATEST NEWS 6FEB'25/GSK PHARMA ...
Exploring GSK's Extensive Product Portfolio
Glaxosmithkline (GSK) Stock Price | GB00BN7SWP63 | News
ESMO26: Evidence for GSK's mo-rez builds in ovarian cancer | pharmaphorum
Pretzel Logic's Market Charts and Analysis: SPX and BKX: "Why Yes. Yes ...
GSK’s Big Cancer Swing Begins to Pay Off With Promising Data
Dehydrated Fruits & Vegetables Market Size, Share, Growth, And Market ...
GSK, Ionis win FDA nod for hepatitis B functional cure that controls ...
GSK: AZUR-1 Data Demonstrates Potential Of Jemperli
Analysis-Now home, Venezuela opposition leader Machado walks tightrope ...
GSK, Ionis hepatitis B functional cure breaks open market for followers ...
Oracle FLEXCUBE Global PAYplus (FGPP) Production Support SME(Remote ...